Compare CUZ & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CUZ | HAE |
|---|---|---|
| Founded | 1958 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.8B |
| IPO Year | 1994 | 1996 |
| Metric | CUZ | HAE |
|---|---|---|
| Price | $29.00 | $109.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $28.00 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 1.2M | 483.3K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.11% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.01 | ★ 0.72 |
| Revenue | ★ $993,816,000.00 | $910,373,000.00 |
| Revenue This Year | $5.61 | N/A |
| Revenue Next Year | $4.23 | $5.23 |
| P/E Ratio | $2,890.00 | ★ $150.72 |
| Revenue Growth | ★ 16.00 | N/A |
| 52 Week Low | $21.03 | $47.32 |
| 52 Week High | $32.95 | $110.45 |
| Indicator | CUZ | HAE |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.